Verification of the Efficacy and Safety of the BAROSTIM NEO System in the Treatment of Drug Resistant Hypertension
Neo Non-Randomized Hypertension Study
Sponsor: CVRx, Inc.
A NA clinical study on High Blood Pressure, this trial is ongoing. The trial is conducted by CVRx, Inc. and has accumulated 14 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
14 versions recorded-
Sep 2025 — Present [monthly]
Active Not Recruiting NA
-
Aug 2025 — Sep 2025 [monthly]
Active Not Recruiting NA
-
Sep 2024 — Aug 2025 [monthly]
Active Not Recruiting NA
-
Aug 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Aug 2024 [monthly]
Active Not Recruiting NA
▶ Show 9 earlier versions
-
Mar 2024 — Jul 2024 [monthly]
Active Not Recruiting NA
-
May 2023 — Mar 2024 [monthly]
Active Not Recruiting NA
-
Jan 2022 — May 2023 [monthly]
Active Not Recruiting NA
-
Jan 2021 — Jan 2022 [monthly]
Active Not Recruiting NA
-
Dec 2019 — Jan 2021 [monthly]
Active Not Recruiting NA
-
Jun 2018 — Dec 2019 [monthly]
Active Not Recruiting NA
-
Mar 2018 — Jun 2018 [monthly]
Active Not Recruiting NA
-
Feb 2017 — Mar 2018 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting NA
First recorded
Jun 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- CVRx, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .